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Targeting genetically encoded tools for neural circuit
dissection to relevant cellular populations is a
major challenge in neurobiology. We developed an
approach, targeted recombination in active popula-
tions (TRAP), to obtain genetic access to neurons
that were activated by defined stimuli. This method
utilizes mice in which the tamoxifen-dependent
recombinase CreERT2 is expressed in an activity-
dependent manner from the loci of the immediate
early genes Arc and Fos. Active cells that express
CreERT2 can only undergo recombination when
tamoxifen is present, allowing genetic access to
neurons that are active during a time window of
less than 12 hr. We show that TRAP can provide se-
lective access to neurons activated by specific
somatosensory, visual, and auditory stimuli and by
experience in a novel environment. When combined
with tools for labeling, tracing, recording, andmanip-
ulating neurons, TRAP offers a powerful approach for
understanding how the brain processes information
and generates behavior.
INTRODUCTION
Our understanding of neural circuits has been greatly facilitated
over the last decade by genetically encoded tools for visualizing
neuronal structure and activity, manipulating neuronal function,
and identifying synaptic connections. The application of these
tools depends critically on the ability to target them to specific
subpopulations of neurons on the basis of criteria such as cell
type and location. For instance, one common strategy to ex-
press a tool in a particular cell type and brain region is to use local
injections of Cre-dependent viruses into genetically engineered
mice that express Cre recombinase in a specific cell type (Zhang
et al., 2010). Other strategies allow neurons to be targeted on the
basis of a variety of anatomical, genetic, and developmental
criteria (Luo et al., 2008). However, in many cases, considerablefunctional heterogeneity exists within neuronal populations that
are anatomically, developmentally, and genetically indistinguish-
able by current methods. For instance, neurons tuned to differ-
ently oriented visual stimuli are intermingled in the rodent primary
visual cortex (Ohki et al., 2005), neurons that are activated by
different odorants are distributed randomly in themouse piriform
cortex (Stettler and Axel, 2009), and neurons activated during
fighting or mating in mice are intermingled in multiple brain areas
(Lin et al., 2011). Even neuronal representations previously
thought to be anatomically organized, such as tonotopically
arranged frequency representations in the auditory cortex, are
now known to be disordered at a fine scale (Rothschild et al.,
2010). The ability to have genetic access to such functionally
similar but spatially distributed and genetically indistinct
neuronal populations would significantly advance our ability to
investigate neural circuits underlying sensory experience and
behavior.
Immediate early genes (IEGs) are the most well-studied
connection between gene expression and a neuron’s electrical
and/or synaptic activity, which defines its response properties.
Exploiting this connection is a promising strategy for gaining
genetic access to active neuronal populations. IEG expression
is low in quiescent cells but can be induced rapidly and tran-
siently by external stimuli. For example, the expression of the
prototypical IEG Fos can be induced in vitro by growth factors
and neurotransmitters and in vivo by neuronal and synaptic
activity, as well as by physiological stimuli (reviewed by Sheng
and Greenberg, 1990). The products of many IEGs, including
Fos, are transcription factors that regulate cellular function
through downstream transcriptional programs, but others can
directly influence neuronal function. For instance, activity-regu-
lated cytoskeleton-associated protein (Arc) is an IEG that
encodes a postsynaptically localized protein that directly influ-
ences synaptic function (Lyford et al., 1995). Fos, Arc, and other
IEGs have been frequently used as markers for neurons that
were active during a short period prior to sacrifice. Although no
single IEG is a perfect surrogate for neuronal activity, throughout
this paper, we use ‘‘activity’’ loosely to refer to IEG expression.
Activity-dependent IEG expression has been exploited in a
number of methods for studying neural circuits. With these
methods, it is possible to identify cells that express IEGs in
response to multiple stimuli separated in time (Guzowski et al.,Neuron 78, 773–784, June 5, 2013 ª2013 Elsevier Inc. 773
Figure 1. Strategy of TRAP, Targeted
Recombination in Active Populations
(A) TRAP requires two transgenes: one that ex-
presses CreERT2 from an activity-dependent IEG
promoter and one that allows expression of an
effector gene, such as tdTomato, in a Cre-
dependent manner. Without tamoxifen (TM),
CreERT2 is retained in the cytoplasm of active cells
in which it is expressed, so no recombination can
occur (top). In the presence of TM, CreERT2
recombination can occur in active cells (bottom),
whereas nonactive cells do not undergo recom-
bination, because they do not express CreERT2.
(B and C) Schematics of the wild-type and
CreERT2 knockin alleles of Fos (B) and Arc (C).
Rectangles indicate exons, and protein-coding
regions are shaded gray. Arrows indicate trans-
lational start sites.
See also Figure S1.
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Targeted Recombination in Active Populations1999), visualize active neurons in fixed or live tissue from trans-
genic animals (Barth et al., 2004; Smeyne et al., 1992; Wang
et al., 2006), and manipulate the activities of IEG-expressing
populations (Garner et al., 2012; Koya et al., 2009; Liu et al.,
2012; Reijmers et al., 2007). Although these strategies have
been useful for addressing many biological questions, they
suffer from a number of limitations, including poor temporal
resolution, transience of effector protein expression, and low
signal-to-noise ratio. Here, we describe an approach using
genetically engineeredmice to obtain permanent genetic access
to distributed neuronal populations that are activated by experi-
ences within a limited time window. This approach, called tar-
geted recombination in active populations (TRAP), offers several
advantages over currently available technologies and, when
combined with genetically encoded effectors for visualizing
and manipulating neurons, has the potential to greatly facilitate
experimental dissection of neural circuit function.
RESULTS
Strategy for Genetically Accessing Neuronal
Populations on the Basis of Immediate Early Gene
Expression
TRAP utilizes two genetic components: (1) a transgene that
takes advantage of IEG regulatory elements in order to express
a drug-dependent recombinase, such as the tamoxifen (TM)-
dependent Cre recombinase CreERT2 (Feil et al., 1997), in an
activity-dependent manner and (2) a transgene or virus that
expresses an effector protein in a recombination-dependent
manner (Figure 1A). For the first component, we generated
knockin mice in which CreERT2 is expressed from the endoge-
nous Fos and Arc loci (Figure 1B and Figure S1 available online).
These knockins retain all sequences 50 to the translational start
site but replace the endogenous 30 untranslated regions
(30UTRs), which contribute to messenger RNA (mRNA) destabili-
zation and Arc mRNA dendritic trafficking (see Supplemental
Experimental Procedures), with an exogenous SV40 polyadeny-
lation signal to promote high-level expression. The introns and774 Neuron 78, 773–784, June 5, 2013 ª2013 Elsevier Inc.coding regions are also displaced (Figures 1B and S1). Although
these alleles are predicted to be null for Arc and Fos, we have not
observed any gross behavioral or anatomical abnormalities in
the resulting heterozygous ArcCreER/+ and FosCreER/+ mice (see
Discussion). For the second component, we used AI14, a
knockin allele of the Rosa26 (R26) locus that allows high-level
ubiquitous expression of the red fluorescent protein tdTomato
after the excision of a loxP-flanked transcriptional stop signal
(Madisen et al., 2010).
In the absence of TM, CreERT2 is retained in the cytoplasm of
active cells and no recombination can occur (Figure 1A, top). TM
administration causes active CreERT2-expressing cells to un-
dergo Cre-mediated recombination (to be ‘‘TRAPed’’), resulting
in permanent expression of the effector gene (e.g., tdTomato;
Figure 1A, bottom). Nonactive cells do not express CreERT2
and do not undergo recombination, even in the presence of
TM. Because of the transient nature of IEG transcription,
CreERT2 is only present for a limited time after neuronal activa-
tion, and the lifetime of TM is limited by metabolism and excre-
tion; as a result, only neurons that are active within a limited
time window around drug administration can be TRAPed.
Background Recombination Is Very Low in FosTRAP
Mice and Is Limited to Specific Cell Types in ArcTRAP
Mice
Because many CreERT2 lines have drug-independent recombi-
nation as a result of leaky CreERT2 activity (e.g., Madisen et al.,
2010), we first examined recombination in FosTRAP (FosCreER/+
R26AI14/+) and ArcTRAP (ArcCreER/+R26AI14/+) mice that were
not treated with TM. Under these conditions, we observed very
few labeled cells (from zero to a few cells per 60 mm sagittal sec-
tion) in both young adult (Figures 2A, top, and 2C, left column)
and aged (6- to 7-month-old; Figures S2B, top, and S2C, right
column) FosTRAP mice. Thus, despite CreERT2 expression in
response to neuronal activity throughout the life of the animal,
cytoplasmic retention of the CreERT2 protein in the absence
of TM prevented CreERT2-induced recombination (Figure 1A,
top). Labeling in untreated ArcTRAP mice is significant but is
Figure 2. Background and Homecage
Recombination in FosTRAP and ArcTRAP
Mice
(A and B) Full sagittal views of FosTRAP (top) and
ArcTRAP (bottom) brains from 6- to 8-week-old
mice that were either uninjected (A) or treated with
TM in the homecage and sacrificed 1 week post-
injection (B). The scale bar represents 1 mm.
(C and D) Magnified views from uninjected (left
columns) or homecage TM-treated (right columns)
FosTRAP (C) and ArcTRAP (D) brains. Images are
representative of at least n = 3 mice examined per
condition. The thalamus images are of the ventral
posteromedial (VPM) thalamus, a somatosensory
thalamic nucleus. S1BF, primary somatosensory
barrel field; CPu, caudate putamen; gl, glomerular
layer; epl, external plexiform layer; mcl, mitral
cell layer; ipl, internal plexiform layer; gcl, granule
cell layer; ml, molecular layer; p, Purkinje cell layer;
and wm, white matter. Numbers indicate cortical
layers. The scale bar represents 100 mm.
See also Figure S2.
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Targeted Recombination in Active Populationsrestricted to a few specific cell types, including layer 6 neurons in
neocortex and granule cells in the dentate gyrus (DG; Figures 2A,
bottom, and 2D, left column). The TM-independent recombina-
tion in ArcTRAP mice is most likely caused by Arc’s relatively
high level of expression (Lyford et al., 1995). Consistent with
this assumption, the frequency of labeled cells in untreated
ArcTRAP mice increased with the animal’s age (Figures S2B,
bottom, and S2D, right column). The remaining experiments in
this paper were performed in mice that were 6–8 weeks of age.
Fos and Arc Loci Drive CreER Activity in Partially
Overlapping Neuronal Populations in the Homecage
Treatment of both FosTRAP and ArcTRAP mice with TM
(150 mg/kg intraperitoneal [i.p.] injected) in the homecage
induced labeling in restricted regions throughout the brain
when mice were examined 1 week postinjection (Figures 2B
and 2C–2D, right columns). Because tdTomato fills cell bodiesNeuron 78, 773–and processes, the identities of recom-
bined cells could readily be determined
by morphology. In FosTRAP mice, we
observed recombination in cells lining
the brain and ventricle surfaces, in blood
vessels, and in putative oligodendrocytes
in white matter. Within the gray matter,
recombination occurred almost exclu-
sively in cells with neuronal morphol-
ogies; recombination in gray matter glial
cells was rarely observed. In ArcTRAP
mice, TM treatment induced labeling
most dramatically in forebrain regions
and was exclusively neuronal. In compar-
ison to uninjected controls, mice injected
with vehicle showed no increase in the
numbers of labeled cells in either line,
indicating that the stimulus of injection
alone was insufficient to trigger recom-bination in the absence of TM (Figures S2A and S2C and S2D,
left columns).
Following homecage TM treatment, ArcTRAP and FosTRAP
mice had similar patterns of recombination in many brain areas
(Figures 2C–2D, right columns), including in neocortex, where
labeled cells were relatively sparse in layer 5; in the hippocam-
pus, where labeled cells were enriched in the DG and in CA1;
in the piriform cortex; and in the olfactory bulb, where granule
cells were heavily TRAPed. Even for those cell types that had
high background recombination in untreated ArcTRAP mice,
TM treatment increased labeling (e.g., compare the left and right
columns in Figure 2D for the hippocampus and neocortical layer
6). In most brain regions, the recombination frequency was
higher in ArcTRAP mice than in FosTRAP mice, but FosTRAP
was more efficient in some areas, such as the cerebellum. In
the thalamus of ArcTRAP mice, no recombination in intrinsic
thalamic neurons was detected despite the presence of densely784, June 5, 2013 ª2013 Elsevier Inc. 775
Figure 3. FosTRAP in the Barrel Cortex of
Whisker-Plucked Mice
(A) Experimental scheme: FosTRAP mice had
either all whiskers except C2 plucked unilaterally
or had only the C2 whisker plucked. After a
2 day recovery period, mice were injected with
150 mg/kg TM, and recombination was examined
7 days later.
(B) Tangential views of flattened layer 4 of the
primary somatosensory barrel cortex (top) or
coronal views through the C2 barrel (bottom).
White dots indicate the corners of the C2 barrel on
the basis of dense DAPI staining of the barrel walls.
Compared with controls (left), removal of only the
C2 whisker results in elimination of TRAP signal
from the C2 barrel (middle), whereas removal of all
whiskers except C2 results in absence of most
TRAPed cells in all barrels except C2 (right). The
left and middle images are from the same mouse.
Images are representative of at least 3–4 mice for
each condition. The scale bar represents 250 mm.
See also Figure S3.
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Targeted Recombination in Active Populationslabeled corticothalamic axons. In contrast, FosTRAP mice
showed efficient recombination in some thalamic nuclei. On
the other hand, medium spiny neurons of the striatum were effi-
ciently labeled with ArcTRAP, but not with FosTRAP.
The high frequency of recombination under homecage condi-
tions in both FosTRAP and ArcTRAPmice contrasts with the low
levels of Fos and Arc expression under similar conditions (Lyford
et al., 1995; Morgan et al., 1987). Given that CreERT2-mediated
recombination is irreversible, TRAPed cells accumulate as long
as TM is present; in addition, perdurance of CreERT2 mRNA or
protein may allow TRAPing of cells activated prior to TM injec-
tion. Thus, the final TRAPed population is a result of activity inte-
grated over a time window determined by CreERT2 stability and
TM metabolism and excretion. In contrast, endogenous Arc and
Fos are rapidly degraded after induction and, thus, report activity
over a more limited time period prior to sacrifice.
The above experiments demonstrate that, with the exception
of a small subset of cell types in the ArcTRAP mice, recombina-
tion in TRAPmice is TM dependent. They also show that Arc and
Fos loci differ to some extent in their cell-type specificities.
Finally, although ArcTRAP has higher background recombina-
tion than FosTRAP, it also has higher TM-induced recombination
(compare the bottom panels of Figures 2A and 2B). Thus, the two
lines may be preferred for certain types of experiments depend-
ing on the relative importance of specificity versus efficiency and
the cell types of interest.
Recombination in the Primary Somatosensory Cortex Is
Dependent on Sensory Input
To determinewhether neurons that are activated by specific sen-
sory stimuli can be TRAPed, we performed sensory deprivation
experiments in the whisker-barrel system of TRAP mice.
Somatosensory information from the facial vibrissae are relayed
via brainstem and thalamic nuclei to contralateral primary776 Neuron 78, 773–784, June 5, 2013 ª2013 Elsevier Inc.somatosensory cortex (S1) where thalamic afferents represent-
ing individual whiskers innervate discrete somatotopically orga-
nized ‘‘barrels’’ in layer 4 (Petersen, 2007). Stimulation of a single
whisker induces IEG expression selectively in the corresponding
barrel (Staiger et al., 2000). Below, we describe results on
FosTRAP mice (Figure 3); however, qualitatively similar results
were obtained with ArcTRAP (Figure S3).
After manipulating sensory input to the barrel cortex by pluck-
ing specific whiskers, we injected mice with TM and returned
them to the homecage with tubes and nesting material to stim-
ulate whisker exploration (Figure 3A). When all whiskers were
left intact, labeled processes and cells were distributed uni-
formly across all barrels (Figure 3B, left), which were visible
both in coronal sections (Figure 3B, bottom) and in sections
tangential to layer 4 (Figure 3B, top). In contrast, when all large
whiskers except C2 were plucked, a dense collection of cells
and processes was apparent in the C2 barrel, with only scat-
tered labeled cells present in other barrels (Figure 3B, right).
This restriction of labeled cells to the C2 barrel extended up to
layers 2/3, but not down to layer 6, where a large number of cells
outside the C2 barrel were labeled (Figure 3B, right). Thus,
TRAPing of cells in the barrel cortex is dependent on specific
sensory input.
Layer 4 barrel neurons can be activated by deflections of
adjacent whiskers (Armstrong-James et al., 1992). To test the
contributions of these nonprincipal inputs to TRAPing, we
repeated the above experiment in mice that had only the C2
whisker removed. We found that, under these conditions, the
corresponding C2 barrel was devoid of labeled cells and pro-
cesses and that this effect was strongest in layer 4 (Figure 3B,
middle). This observation suggests that Fos expression in layer
4 is evoked mainly by thalamocortical input, either directly by
thalamocortical synapses or indirectly by intracortical connec-
tions within a barrel.
Figure 4. Time Window for Effective
TRAPing Relative to Drug Injection in Pri-
mary Visual Cortex
(A) Experimental scheme: FosTRAP mice were
placed in constant darkness for 2 days and were
then given injections of either 150 mg/kg TM or
50 mg/kg 4-OHT at varying times relative to a 1 hr
diffuse light stimulus. Mice remained in darkness
for three days after drug injection and were sacri-
ficed 7 days later.
(B and C) Representative images of primary visual
(V1, top rows) and somatosensory (S1, bottom
rows) cortices inmice treatedwith TM (B) or 4-OHT
(C) at different times relative to the light stimulus.
The scale bar represents 250 mm.
(D) Quantification (mean ± SEM, n = 4–7 mice
per time point) of the density of TRAPed cells in
V1 and S1 normalized to the mean density of
TRAPed cells in the dark condition for both TM
(top) and 4-OHT (bottom). In S1 of mice treated
with either drug, light stimulation did not increase
the number of TRAPed cells over dark levels
(ANOVAs, p > 0.3). For V1, the window for TRAPing
was longer and had a later peak for TM than for
4-OHT. ***, significantly different from the dark
condition for V1 (p < 0.001, Tukey’s post hoc test
after significant ANOVA). All other time points were
not significantly different from dark (p > 0.05).
See also Figures S4 and S5.
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Targeted Recombination in Active PopulationsDifferent Forms of Tamoxifen Allow Activity to Be
TRAPed Over Different Time Windows
We performed additional characterization of TRAP in the visual
system, where IEG expression can be robustly induced by light
(Kaczmarek and Chaudhuri, 1997), focusing on FosTRAP
because of its low TM-independent background. Light stimula-
tion increased the numbers of TRAPed cells in the dorsal lateral
geniculate nucleus (dLGN) and primary visual cortex (V1) by 4.2-
and 8.3-fold, respectively, relative to mice maintained in the dark
(Figures 4 and S4A–S4C). The TRAPed cells were distributed
across all layers of V1 but were most dense in layer 4, and
more than 96% of the TRAPed cells expressed the neuronal
marker NeuN; the remaining 4% of cells included putative
endothelial cells and glia (Figure S4E). Fewer than 3% of V1
cells were GABAergic (Figure S4E). Thus, most TRAPed cells
in V1 are excitatory neurons.
To determine the time window around a TM injection during
which active cells are efficiently TRAPed, we examined V1 in
FosTRAP mice that had been stimulated with 1 hr of diffuse
bright light at various times relative to the injection (Figure 4A).
TRAPing was maximal when light stimulation occurred 23–
24 hr after injection. No TRAPing above the level of the dark con-
trol occurred when light was given 6–7 hr before the injection or
35–36 hr after injection (Figures 4B and 4D). Labeling in a control
region (S1) was similar across all time points (Figures 4B and 4D).
Thus, under these conditions, TRAP appears to be sensitive to
neuronal activation that occurs less than 6 hr prior to injection
and up to 24–36 hr after injection.
A long timewindowmay be desirable in caseswhere it is bene-
ficial to TRAP cells on the basis of the integration of activity over a
long period of time. However, applications that utilize stimuli and
experiences of short duration could benefit from a shorter timewindow. After injection, TM is metabolized to its principal active
form, 4-hydroxytamoxifen (4-OHT; Robinson et al., 1991).
Directly injecting 4-OHT shortened the TRAPing time window
to <12 hr (Figure 4D); optimal TRAPing in V1 was observed
when light was administered in the hour immediately before
injection of 4-OHT, and minimal TRAPing was observed when
light was delivered 6–7 hr before or 5–6 hr after the injection.
To determine the dependence of TRAP on stimulus duration,
we delivered light pulses of varying durations beginning 1 hr
before a 4-OHT injection. Relative to mice left in the dark, mice
exposed to light pulses of 5, 15, and 60 min in duration had
2.6-, 4.9-, and 8.3-fold more TRAPed cells in V1 (Figures S5A–
S5C). Thus, even short (5 min) stimuli are sufficient for TRAPing,
although longer duration stimuli increase the total numbers of
TRAPed cells. These results are consistent with prior findings
that the induction of Fos protein in V1 is dependent on stimulus
duration (Amir and Robinson, 1996).
The time course of effector expression after TRAPing deter-
mines the earliest time point at which subsequent experimental
manipulations are possible. Although this parameter is most
likely to be dependent on effector and cell type, we found that
it took at least 72 hr following light stimulation and 4-OHT injec-
tion for TRAPed V1 cells to express sufficiently high levels of
tdTomato to be reliably identified (Figures S5D–S5F).
TRAP Provides Selective Genetic Access to Cochlear
Nucleus Neurons Tuned to Specific Sound Frequencies
Next, we took advantage of the tonotopic organization of the
auditory system to evaluate whether TRAP can provide genetic
access to cell populations that are activated by particular fea-
tures of sensory stimuli. We focused on the cochlear nucleus
(CN), all three subdivisions of which receive input from spiralNeuron 78, 773–784, June 5, 2013 ª2013 Elsevier Inc. 777
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Targeted Recombination in Active Populationsganglion neurons (SGNs) that carry auditory information from the
cochlea. SGNs that innervate the apex or the base of the cochlea
are tuned to low- and high-frequency sounds and terminate their
axons in the ventral or dorsal regions of each CN subdivision,
respectively. Thus, SGN axons are arrayed in a high-to-low-
frequency tonotopic map along the dorsoventral axis of the CN
(Young and Oertel, 2004). Similar tonotopy is observed in CN
neuronal responses themselves, determined both electrophysi-
ologically (Luo et al., 2009) and by Fos induction (Friauf, 1992;
Saint Marie et al., 1999).
We injected FosTRAP mice with 4-OHT during a 4 or 16 kHz
continuous pure tone stimulus to TRAP CN neurons tuned to
those frequencies. To increase the total number of TRAPed cells,
we took advantage of TRAP’s ability to integrate IEG expression
over time by using a 4 hr pure tone stimulus during the TRAPing
period. Then, 4–5 days later, we delivered a second 4 or 16 kHz
stimulus for 1 hr, sacrificed themice 1 hr later, and processed the
tissue for Fos immunostaining (Figure 5A). Thus, TRAPed cells
represent neurons activated by the first stimulus, and Fos protein
immunopositive (Fos+) cells represent neurons activated by the
second stimulus.
Consistent with prior results, we found that 4 kHz stimulation
during the second epoch induced Fos expression in clusters of
cells in all three CN subdivisions that were locatedmore ventrally
than the clusters that were Fos+ after 16 kHz stimulation. Similar
results were observed for TRAPed cells. When the tone fre-
quency was the same for the two stimulus epochs, the TRAPed
and Fos+ populations overlapped, and the 4 kHz cluster was
localized more ventrally than the 16 kHz cluster (Figure 5B, first
and third columns). Within mice receiving stimuli of two different
frequencies, the cells TRAPed by the 16 kHz stimulus were
dorsal to Fos+ cells induced by the 4 kHz stimulus (Figure 5B,
second column), whereas the reverse was true when the 4 kHz
stimulus was TRAPed and the 16 kHz representation was re-
vealed by Fos immunostaining (Figure 5B, last column). These
qualitative impressions were confirmed by the quantification of
the numbers of TRAPed and Fos+ cells in bins spanning the
dorsoventral axis of the central dorsal cochlear nucleus (DCN;
Figure 5C). In general, the populations of TRAPed cells were
less sharply confined along the dorsoventral axis than the popu-
lation of Fos+ cells. This may reflect the longer stimulus used for
TRAPing (4 hr, versus 1 hr for Fos immunostaining) or some
general noise in the TRAP approach. Regardless, this analysis
supports the observations from individual sections that both
TRAP and Fos immunostaining reveal similar tonotopic maps
along the dorsoventral axis of the DCN.
We also quantified the overlap between TRAPed and Fos+
cells for the different treatment groups across the entire extent
of the DCN. As expected, the overlap between the two popula-
tions was greater when the stimuli during the two epochs were
the same (4kHz-4kHz and 16kHz-16kHz groups) than when the
stimuli during the two epochs were different (16kHz-4kHz and
4kHz-16kHz groups; Figure 5D). The partial overlap in the
16kHz-4kHz and 4kHz-16kHz groupswas not unexpected, given
the complexity of the tuning curves for some types of CN neu-
rons (Luo et al., 2009; Young and Oertel, 2004). The fact that
70% of Fos+ cells were also TRAPed in the 16kHz-16kHz
and 4kHz-4kHz groups (Figure 5D, left) suggests that TRAP778 Neuron 78, 773–784, June 5, 2013 ª2013 Elsevier Inc.can provide genetic access to the majority of cells that express
Fos in response to a particular stimulus. Our finding that only
30%–40% of TRAPed cells were Fos+ in these groups (Fig-
ure 5D, right) could be due to some noise intrinsic to the TRAP
approach or to greater sensitivity of TRAP relative to Fos immu-
nostaining; alternatively, it could be due to the TRAPing of cells
that expressed Fos in response to the long-duration stimulus
used during the TRAPing period but that did not express Fos in
response to the shorter stimulus delivered prior to sacrifice.
Neurons Activated by Complex Experiences Can Be
Effectively TRAPed
Although the experiments in the somatosensory, visual, and
auditory systems suggest that TRAP can have high signal-to-
noise ratio in the context of sensory deprivation and controlled
stimulation, we wanted to evaluate whether it would also be
possible to TRAP neurons activated by complex experiences.
To this end, we allowed FosTRAP mice to explore a novel envi-
ronment for 1 hr, injected them with either 4-OHT or vehicle,
and allowed them to continue exploring the novel environment
for another 1 hr. An additional group of mice received 4-OHT
injections in the homecage. Mice were sacrificed 1 week after
treatment. Virtually no cells were TRAPed in any brain region in
mice given an injection of vehicle during novel environment
exploration (Figures 6A and S6A), confirming that CreER activity
is tightly regulated by tamoxifen. In comparison to 4-OHT-
injected homecage controls, mice injected with 4-OHT in a novel
environment had more TRAPed cells throughout the brain. For
instance, novel environment exploration increased the numbers
of TRAPed cells in piriform and barrel cortices by 1.9- and 3.5-
fold, respectively (Figure S6), consistent with prior studies using
in situ hybridization or immunohistochemistry to detect IEGs
(Hess et al., 1995; Staiger et al., 2000). Interestingly, the TRAPing
of oligodendrocytes in the white matter was not affected by
novel environment exposure (Figure S6), suggesting that the
differences in neuronal TRAPing were not due to variability in
4-OHT dosing or metabolism.
We also found that exploration of the novel environment
increased the numbers of TRAPed DG granule cells and CA1
pyramidal cells by 2.4- and 2.9-fold, respectively, in comparison
to homecage controls (Figure 6). This result is consistent with
previous work using in situ hybridization to detect IEGs (Guzow-
ski et al., 1999; Hess et al., 1995). TRAPed cells in CA3 were very
sparse in all conditions. In the DG, more TRAPed cells were
located in the upper (suprapyramidal) blade than in the lower
(infrapyramidal) blade (Figure 6C). The increased TRAPing of
DG granule cells with novel environment exploration was also
greater in the upper blade than in the lower blade (Figure 6C),
consistent with prior reports of an upper-blade-selective in-
crease in Arc expression in rats exploring a novel environment
(Chawla et al., 2005). Although the significance of this apparent
functional difference between upper and lower blades is unclear,
our data, along with prior results, suggest that it is consistent for
different IEGs and across rats and mice. Moreover, TRAP can
capture patterns of DG activity consistent with those obtained
with classical methods, and TRAP has a sufficient signal-to-
noise ratio in the absence of sensory deprivation to detect
neuronal activity associated with complex experiences.
Figure 5. TRAPing Cells that Respond to Specific Frequencies of Auditory Stimuli
(A) Experimental scheme: FosTRAPmice were placed in a sound isolation chamber for 24 hr, during which they received a 4 hr pure tone stimulus (magenta bar).
In the middle of the stimulus, they were injected with 50 mg/kg 4-OHT. Then, 4–5 days later, they were returned to the sound isolation chambers, where they
received a 1 hr pure tone stimulus (green bar) ending 1 hr before they were sacrificed.
(B) Exemplary images of the dorsal, anteroventral, and posteroventral cochlear nuclei (DCN, AVCN, and PVCN, respectively), the cores of which are outlined with
white dots on the basis of a DNA counterstain (data not shown). Fos immunostaining is shown in green, and magenta shows tdTomato fluorescence from TRAP.
For the group names above each column, the frequencies represented by the TRAPed and Fos+ cells are indicated in magenta and green, respectively. Magenta
and green arrows indicate the qualitative centers of TRAPed and Fos+ cell clusters, respectively, within each subdivision. The CN borders include granule cells
that receive extensive nonauditory input (Young and Oertel, 2004) and that are thus TRAPed independently of the delivered stimulus. Similar results were
observed in all 3–4 mice in each group. The scale bar represents 250 mm.
(C) Quantification of tonotopy in the DCN. Sections from the middle third of the rostrocaudal extent of the DCN were separated into bins along the dorsoventral
axis (shown in the upper left panel in B), and the numbers of TRAPed (magenta histogram) and Fos+ (green histogram) cells (excluding granule cells) were counted
for each bin and pooled across sections and animals. Total cell counts are 300–700 for the each of the Fos+ (green) histograms and 800–1,500 for each of the
TRAP (magenta) histograms. Regardless of whether the neuronal representation was measured by Fos immunostaining or by TRAP, the higher-frequency tone
activated cells localized more dorsally than the lower-frequency tone.
(D) Quantification (mean ± SEM, n = 3–4 mice per condition) of colabeling between TRAP and Fos immunostaining. For both plots, all groups were significantly
different from each other (Tukey’s post hoc tests, p < 0.05 after ANOVA, p < 0.001), except for 4kHz-4kHz versus 16kHz-16kHz and 16kHz-4kHz versus 4kHz-
16kHz (p > 0.05).
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Targeting genetically encoded effectors to relevant neuronal
populations is a key step in many experiments aimed at deci-
phering how the brain processes information and generates
behavior. Although neurons have traditionally been targeted on
the basis of anatomical, developmental, or genetic criteria,
TRAP allows neurons to be targeted on the basis of a functionalcriterion: whether or not they are activated by particular stimuli or
experiences.
Applications of TRAP and Comparison to Other
Approaches
Although the experiments reported here utilized a fluorescent
protein as a reporter for TRAPed neurons, our FosCreER and
ArcCreER knockin alleles can be combined with differentNeuron 78, 773–784, June 5, 2013 ª2013 Elsevier Inc. 779
Figure 6. TRAPing Cells Activated by the
Exploration of a Novel Environment
(A) Representative images of the hippocampus
from FosTRAPmice that were injectedwith vehicle
or 50 mg/kg 4-OHT while exploring a novel envi-
ronment for 2 hr (left and right, respectively) or with
50 mg/kg 4-OHT in the homecage (middle). Mice
were sacrificed 1 week after injection. Higher-
magnification images of CA1 (middle) and the DG
(bottom) correspond to the boxed regions in the
top row. Virtually no cells were TRAPed in the
vehicle-injected mice. In 4-OHT-injected mice,
exploration of a novel environment led to an in-
crease in TRAPed DG granule and CA1 pyramidal
cells in comparison to mice left in the homecage.
In the DG, TRAPed cells were located mostly in
the upper (suprapyramidal) blade, indicated in the
lower left panel as the region above the yellow line
bisecting the genu. The highly TRAPed region in
the upper right panel (y) is the barrel cortex (see
Figure S6). TRAPing of cells with axons innervating
the DG also increases with novel environment
exposure, as indicated by the increase in diffuse
tdTomato labeling of the DG molecular layer (*).
The scale bar represents 100 mm.
(B) Quantification (mean ± SEM) of numbers of
TRAPed DG granule cells and CA3 and CA1
pyramidal cells in mice treated with 4-OHT in the
homecage (n = 6) or during the exploration of a
novel environment (n = 6) or in mice treated with
vehicle while exploring a novel environment (n = 3). Cell counts represent the total numbers of cells observed on one side of the hippocampus in every fourth
coronal section across all but the most caudal portion of the hippocampus. Novel environment exploration significantly increased the numbers of TRAPed DG
granule cells and CA1 pyramidal cells (***, p < 0.001; **, p < 0.01; Tukey’s post hoc test after a significant two-way ANOVA with brain region and treatment as
factors; statistical results for the vehicle controls were not determined because of the small number of cells observed in that condition).
(C) Quantification (mean ± SEM) of density of TRAPed DG granule cells in the upper and lower blades of the DG in mice treated with 4-OHT in the homecage or
while exploring a novel environment (***, p < 0.001, Tukey’s post hoc test; **, p < 0.01, blade X treatment interaction by two-way ANOVA).
See also Figure S6.
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range of different effectors in TRAPed cells. This modular design
will enable genetic manipulation of the TRAPed population for
visualizing structure (with fluorescent proteins), recording activ-
ity (with genetically encoded calcium indicators), identifying syn-
aptic connections (with genetically targeted viral transsynaptic
tracers), or manipulating activity (with optogenetic and pharma-
cogenetic effectors).
Labeling Neurons Activated by a Single Experience
Detection of IEG expression by immunostaining or in situ hybrid-
ization enables high-resolution, whole-brain identification of
neurons activated in unrestrained animals by experiences that
occur within a limited timewindowbefore sacrifice. The develop-
ment of transgenic animals and viruses that express fluorescent
reporters from IEG-regulatory elements has allowed IEG-ex-
pressing neurons to be studied in live animals and tissues (Barth
et al., 2004; Kawashima et al., 2009; Wang et al., 2006). With
TRAP, effector proteins can be expressed from a strong pro-
moter, enabling higher-level expression than is likely to be
achieved by direct expression from activity-dependent ele-
ments. Thus, TRAP can facilitate experiments where strong
labeling is important, such as whole-brain imaging of cells acti-
vated by an experience with tissue-clearing methods or calcium
imaging of TRAPed neurons with genetically encoded calcium
indicators (Zariwala et al., 2012).780 Neuron 78, 773–784, June 5, 2013 ª2013 Elsevier Inc.Furthermore, becausemarker protein expression with TRAP is
permanent, analysis of TRAPed cells can be performed long
after TRAPing has occurred. This increased temporal flexibility
can be utilized to allow the fluorescent marker to diffuse
throughout the cell to reveal detailed neuronal morphologies;
for instance, long-distance corticothalamic axons from layer 6
neocortical cells were strongly labeled in TRAP mice with the
tdTomato reporter (Figure 2). The distribution of synapses
made by TRAPed cells can be visualized with synaptically local-
ized fluorescent probes (e.g., Li et al., 2010; see also JAX stock
#012570). This temporal flexibility is also advantageous for opto-
genetics applications, where efficient membrane trafficking and
high expression level are critical (Zhang et al., 2010).
Distinguishing between Neurons Activated by Two
Experiences
By distinguishing between nuclear and cytoplasmic transcripts
of a single IEG or between the transcripts of two IEGs that
are produced with different kinetics, compartment analysis of
temporal activity by fluorescence in situ hybridization (catFISH)
allows cells activated by two temporally separated stimuli to
be identified. For catFISH, the two stimuli must be brief (typically
5 min), and they must be delivered in a restricted time window
(typically immediately before and 30 min before sacrifice;
Guzowski et al., 1999). As demonstrated in Figure 5, TRAP can
be used to identify populations of cells activated during two
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Targeted Recombination in Active Populationsdifferent epochs with fewer temporal constraints than catFISH.
With TRAP, cells active during the TRAPing period are geneti-
cally marked by the effector, and cells active shortly before the
animal is sacrificed are marked by the expression of an IEG.
The minimal time between stimulus epochs is only limited
by the timecourse of effector expression (e.g., 3 days for
tdTomato; Figure S6), and, because effector expression is per-
manent, there is no upper limit for the time between epochs.
The combination of TRAP and fluorescent reporters of IEG
expression (Barth et al., 2004; Kawashima et al., 2009; Wang
et al., 2006) will extend the experimental possibilities by allowing
cells active during two stimulus epochs to be studied in vivo.
The pioneering TetTag method also allows labeling of popula-
tions of cells active during two temporally distant epochs
(Reijmers et al., 2007). TetTag utilizes a Fos-tTA transgene in
which the tetracycline transactivator tTA is driven by a fragment
from the Fos promoter. A second tTA-dependent transgene ex-
presses a label along with a constitutively active form of tTA
(tTA*). Removal of the tTA inhibitor doxycycline opens a time
window during which tTA in active cells drives tTA* expression
in order to initiate a positive feedback loop that produces perma-
nent expression of tTA*, which ismaintained even after the return
of doxycycline. Thus, neurons active during the absence of
doxycycline will be permanently tagged, whereas neurons active
shortly before sacrifice can be identified by IEG immunostaining
(Reijmers et al., 2007).
TRAP has several advantages over TetTag. Although the time
window for effective tagging with TetTag has not been reported,
it is likely to be very long because of the slow timecourse of
tTA activation following removal of doxycycline; maximal tTA-
dependent gene expression is reached only up to two weeks
after stopping Dox administration (Glazewski et al., 2001). In
contrast, we show that TRAP can integrate activity over a time
window of <12 hr (Figure 4). The transcriptional positive feed-
back loop that maintains expression of the label with TetTag
may also not be fully self-perpetuating, such that tagging with
TetTag is not completely permanent. Because recombination
is irreversible, labeling with TRAP is permanent. TetTag also suf-
fers from relatively high background levels of tagging, even in
mice that are maintained on doxycycline (Liu et al., 2012;
Reijmers et al., 2007) and in mice that have only the tTA* and re-
porter transgenes without the Fos-tTA component (K.M., unpub-
lished data). In contrast, FosTRAP produces essentially no
recombination in the absence of TM (Figure 2), and background
levels of recombination with TM are low in sensory systems that
are deprived of input (Figures 2–4).
Manipulating the Activities of Transiently Active
Neurons
Expression of optogenetic and pharmacogenetic effectors for
reactivation and inhibition of the TRAPed population is an
exciting future direction. The Daun02 inactivation method is
one alternative approach for inactivating a neuronal population
defined by IEG expression (Koya et al., 2009). This method uti-
lizes Fos-lacZ rats that are injected with Daun02, a prodrug
that is converted by the lacZ product to daunorubicin, a putative
inhibitor of neuronal activity. Recently active cells that express
lacZ are thought to be selectively inactivated after converting
Daun02 to daunorubicin, although the nature and time courseof this inactivation is not well characterized (Koya et al., 2009).
Because TRAP can be combined with many well-characterized
optogenetic and pharmacogenetic tools, it offers greater flexi-
bility than the Daun02 inactivation method. As an alternative,
the Fos-tTA component of TetTag has been used to drive the
expression of optogenetic and pharmacogenetic tools from
viruses (Garner et al., 2012; Liu et al., 2012). This strategy suffers
from many of the same limitations as TetTag, including poor
temporal resolution and high background. In addition, with the
Fos-tTA transgene alone, tagging is not permanent; subsequent
analysis or manipulation of the tagged population after the return
of doxycycline is limited by the perdurance of the effector protein
in the absence of active transcription.
Other Genetic Manipulations
Besides the expression of fluorescent labels and of optogenetic
and pharmacogenetic tools, additional genetic manipulations of
the TRAPed population are also possible. For instance, TRAP
can be combined with rabies-virus-based genetically targeted
trans-synaptic tracing methods in order to identify neurons that
connect to TRAPed cells (Miyamichi et al., 2011; Wickersham
et al., 2007). By expressing Cre-dependent transgenes (e.g.,
wild-type genes for gain-of-function experiments or dominant-
negative alleles for loss-of-function experiments) or utilizing
loxP knockin alleles for Cre-dependent inactivation of a gene,
it will also be possible to manipulate genes and proteins in the
TRAPed population. These strategies will be useful both for char-
acterizing the roles of the targeted genes and proteins as well as
for manipulating the functions of the TRAPed population. The
efficiency of Cre recombination is an important consideration
for such experiments, given that we have found efficient Cre-
dependent transgenes to be critical for successful TRAPing
(data not shown). Fortunately, many high-efficiency transgenes
identical in locus and design to the AI14 transgene used here
have been developed for Cre-dependent expression of fluores-
cent proteins, optogenetic tools, and calcium indicators (Madi-
sen et al., 2012; Madisen et al., 2010; Zariwala et al., 2012). In
addition, advances in site-specific transgenesis techniques
now allow the rapid development of additional high-efficiency
Cre-dependent transgenes (Tasic et al., 2011). We have also
successfully used TRAP in conjunction with viral expression of
effector genes (data not shown).
The Nature of the TRAPed Population
An understanding of the features of neuronal activity that lead to
IEG expression and TRAPing will be important for applying
TRAP. The relationship between synaptic activity and IEG
expression is not completely understood and appears to be
dependent on many factors. In some cases, spiking alone is
sufficient for IEG induction (Schoenenberger et al., 2009),
whereas, in other cases, synaptic activation is critical (Luckman
et al., 1994). The precise pattern of activity, as well as the
duration and intensity of activity, affects IEG induction, and
different IEGs have different thresholds of induction (Sheng
et al., 1993; Worley et al., 1993). In addition, TRAP is binary (cells
are either TRAPed or not), whereas IEG expression is graded
(Schoenenberger et al., 2009; Worley et al., 1993). The probabil-
ity of TRAPing is an unknown function of CreERT2 expression
level during the critical time window surrounding TM or 4-OHTNeuron 78, 773–784, June 5, 2013 ª2013 Elsevier Inc. 781
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bility, IEG and CreERT2 expression level, and neuronal activity in
TRAP are unknown, the electrophysiological responses of the
TRAPed population to the experimental stimulus are difficult to
predict a priori. On one extreme, the TRAPed population may
be a small, stochastic subset of a large population of cells that
was weakly activated by the stimulus. On the other extreme,
the TRAPed population may be a large percentage of a small
population of cells that was strongly activated by the stimulus.
Although more effort is necessary to fully distinguish between
these possibilities, our observation of good correspondence
between TRAPing and Fos expression in the cochlear nucleus
(Figure 5) suggests that, at least in this system, the TRAPed pop-
ulation consists mostly of neurons that reliably express Fos at
high levels in response to repeated presentation of the same
stimulus. Through in vivo targeted electrophysiological and
imaging experiments, it will be possible in the future to charac-
terize the physiological responses of a TRAPed population.
Such experiments will improve our understanding of how IEG
expression is related to cells’ physiological properties.
Limitations and Possible Future Improvements of TRAP
The cell-type specificity of TRAP is a limitation for some applica-
tions. For instance, we found that, after visual stimulation,
GABAergic cells were underrepresented among the TRAPed
population (Figure S4). This is consistent with prior work using
Fos immunostaining in cats and rats (Mainardi et al., 2009; Van
der Gucht et al., 2002). TRAPing of GABAergic cells is likely to
be dependent on the stimulus and brain region, andwe observed
robust TRAPing of some inhibitory neuron types, such as olfac-
tory bulb granule cells and striatal medium spiny neurons (Fig-
ure 2). Thus, much of TRAP’s cell type specificity is derived
from the cell-type specificity of IEG expression. Additional fac-
tors, such as the displacement of regulatory elements during
gene targeting, cell-type differences in the accessibility of the
effector locus for recombination, and cell-type differences in
the regulation and trafficking of CreERT2 could potentially
contribute. Nonetheless, we show that most cell types in the
brain can be TRAPed with the current version of the method.
Future modifications, such as the development of CreERT2
knockin alleles for IEGs that are expressed in different neuronal
types and that are sensitive to different features of neuronal
activity (Schoenenberger et al., 2009; Worley et al., 1993), could
extend the approach to cell types that currently cannot be
robustly TRAPed.
Another concern is that our CreERT2 knockin alleles are ex-
pected to be null for Fos and Arc. We did not observe any abnor-
malities in ArcTRAP or FosTRAP mice, and we are not aware of
any severe phenotypes in previously generated Arc and Fos
heterozygous knockout mice (Johnson et al., 1992; Paylor
et al., 1994; Wang et al., 2006; Wang et al., 1992). However,
some subtle phenotypes of Arc or Fos haploinsufficiency have
been reported. These include a low penetrance of increased
seizure susceptibility in Arc+/ mice (Peebles et al., 2010), and,
for Fos+/ mice, increased susceptibility to drug-induced neuro-
toxicity (Deng et al., 1999) and attenuated morphological
changes associated with kindling stimuli in an epilepsy model
(Watanabe et al., 1996). Although these phenotypes are unlikely782 Neuron 78, 773–784, June 5, 2013 ª2013 Elsevier Inc.to affect many TRAP experiments, alternative knockin or trans-
genic strategies that do not produce null alleles could mitigate
such concerns.
Given that considerable recombination is induced in many
brain areas that process sensory information even under home-
cage conditions, the use of sensory deprivation is useful for
improving TRAP specificity (Figure 2). Some noise is likely due
to the still relatively long <12 hr period surrounding 4-OHT injec-
tion in which any highly active neurons can be TRAPed, regard-
less of whether or not their activity is related to the experimental
stimulus. The use of a destabilized form of CreERT2, the inclusion
of endogenous sequences in the Fos and Arc 30UTRs that
contribute to mRNA destabilization, the development of new
CreER ligands that are more rapidly absorbed and metabolized
than 4-OHT, and the development of drug-dependent recombi-
nases with reduced leakiness and improved inducibility may
result in an improved signal-to-noise ratio. Nonetheless, com-
plex experiences, such as exploration of a novel environment,
can increase TRAPing above homecage levels (Figure 6), sug-
gesting that the current version of TRAP has sufficient signal-
to-noise ratio without sensory deprivation.
Despite the limitations, we have shown that TRAP provides
valuable genetic access to active populations of neurons with
feature selectivity in multiple systems. Thus, TRAP can be
used in combination with various Cre-dependent effectors to
trace connectivity, record activity, and manipulate functions of
these select neuronal populations. Although previous methods,
such as TetTag, also enabled genetic manipulation of function-
ally defined neuronal populations, TRAP’s superior temporal
resolution and its ability to provide permanent genetic access
make it a major advancement that has the potential to enable
previously impossible experiments.EXPERIMENTAL PROCEDURES
Methods for mouse production and histology can be found in the Supple-
mental Experimental Procedures. All mouse procedures were approved by
the Stanford University Administrative Panel on Laboratory Animal Care and
were in accordance with all applicable regulatory standards. ArcCreER (JAX
stock #021881) and FosCreER (JAX stock #021882) mice can be requested
from the Jackson Laboratory.
Tamoxifen Induction
In pilot experiments, we tested a range of TM doses (30–150mg/kg) and found
that TM-induced recombination was highly nonlinear. Low TM doses
(30 mg/kg TM) induced minimal recombination, particularly in the less-sensi-
tive FosTRAPmice (data not shown). Given that 150mg/kg TM induced robust
recombination and was well tolerated by the mice, this dose was used for
further studies. Similarly, 15 mg/kg 4-OHT induced minimal recombination in
FosTRAP mice, whereas 150 mg/kg 4-OHT was not well tolerated. For addi-
tional studies, 50 mg/kg was used. In V1 (see Figure 4), treatment with
150 mg/kg TM and 50 mg/kg 4-OHT produced similar total numbers of
TRAPed cells both in the dark condition (4-OHT, 622 ± 110 cells/mm3; TM,
777 ± 191 cells/mm3; t[7] = 0.65, p = 0.53) and when administered at the
time point for optimal TRAPing (0 hr 4-OHT, 5184 ± 605 cells/mm3; 24 hr
TM, 5736 ± 731 cells/mm3; t[9] = 0.57, p = 0.59). We also found that 4-OHT
produced more consistent results than TM. In 5%–20% of mice treated with
TM, induction appeared to fail altogether, and so few cells were labeled that
the mice were excluded from analysis. Similar failures were never observed
in mice treated with 4-OHT. For details of TM and 4-OHT preparation, see
the Supplemental Experimental Procedures.
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For barrel cortex experiments, mice were anesthetized with 100 mg/kg keta-
mine and 10 mg/kg xylazine i.p. injected, and whiskers were removed under
a dissection scope by grasping them at the base with forceps and pulling. After
whisker removal, mice were singly housed, and whiskers did not regrow sub-
stantially by the time of tamoxifen injection two days later. Approximately 6 hr
after TM injection, mice were provided with cardboard tubes (approximately
3.5 cm in diameter) and nesting material to stimulate whisker exploration.
For visual stimulation, the homecages of singly housed mice were placed in
individual light-tight cubicles with white walls. Light stimuli were delivered by
an LED bulb mounted above the cage, which produced light of 500 lux at
cage level. Drugs were injected with a dim red LED in an otherwise dark
room. For the time course experiment, light was delivered at the same time
of day (starting at 8 hr after the subjective dawn of the animal’s former light/
dark cycle) to all mice in order to control for possible circadian differences in
sensitivity to stimulation, and the timing of drug injections was varied around
this fixed time.
For auditory stimulation, mice were placed into custom sound isolation
cubicles lined with acoustic foam (Auralex Acoustics). Sound stimuli were
generated in Audacity (https://audacity.sourceforge.net), produced by a PC
sound card (Creative Labs), amplified (Onkyo), and delivered by a speaker
(Fostex) mounted directly above the animal’s cage. Stimuli were delivered at
approximately 90 dB.
For the novel environment experiments, mice were group housed until at
least 3 days before the start of the experiment, at which point they were singly
housed in standard 20 3 30 cm mouse cages in a normal colony room. Novel
environment experiments were performed beginning 1–3 hr after the onset of
the animals’ dark cycle, at which point experimental mice were transported to
a separate room and placed in a dimly lit (<10 lux) 303 60 cm plastic cage with
a running wheel, a wooden or plastic ‘‘hut,’’ a plastic tunnel, wooden chips for
chewing, and buried food. After 1 hr, mice were removed from the novel envi-
ronment and injected with either 4-OHT or vehicle before they were returned to
the novel environment for another 1 hr, at which point they were returned to the
homecage in the animal colony for 1 week before sacrifice. Homecage control
mice were similarly injected with 4-OHT 1–3 hr after the onset of the dark cycle
under dim white light 1 week prior to sacrifice.
For all experiments, mice were subjected to only the minimal handling
necessary for genotyping and colony maintenance prior to performing the
experiments.
Data Analysis
Details of cell counting and quantification are available in the Supplemental
Experimental Procedures. Statistical analyses were performed in Prism
(GraphPad).
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.neuron.2013.03.025.
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